Key result
Exenatide improves islet function in obese diabetic rats by up-regulating ABCA1 to promote cholesterol efflux.
Why the study?
Obese diabetic rats exhibit lowered ABCA1 expression, cholesterol efflux block, and cholesterol accumulation in pancreatic tissue, motivating study of exenatide effects.
Does exenatide promote cholesterol efflux and improve islet function in obese diabetic rats?
Does exenatide promote cholesterol efflux and improve islet function in obese diabetic rats?
Exenatide improves islet function and promotes cholesterol efflux in the pancreas of obese diabetic rats, suggesting a potential mechanism for its benefits in diabetes.
Exenatide may enhance pancreatic cholesterol efflux in diabetic rat models; leaves open any role in human islet preservation.
OBJECTIVE: To study the effect of exenatide on the expression of ABCA1 and cholesterol metabolism in the pancreas of obese diabetic rats. OBJECTIVE: Twenty-four normal male SD rats and 18 obese diabetic rats (induced by high-fat feeding and STZ injection) were both divided equally into 2 groups for injections of saline or exenatide. After treatment for a week, the expression of ABCA1, cholesterol metabolism, and islet function of the rats were examined using real-time PCR, Western blotting, oil red O staining, cholesterol content determination, and HE staining. OBJECTIVE: < 0.05). OBJECTIVE: Obese diabetic rats have lowered ABCA1 expression, cholesterol efflux block, and cholesterol accumulation in the pancreatic tissue. Exenatide can up-regulate ABCA1 expression and promote cholesterol efflux to reduce cholesterol content in the pancreatic tissue and improve islet function in obese diabetic rats.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2021) studied Obese diabetes (n=42). Exenatide vs. Saline was evaluated on Expression of ABCA1, cholesterol metabolism, and islet function (p=< 0.05). Exenatide up-regulated ABCA1 expression, promoted cholesterol efflux, reduced pancreatic cholesterol content, and improved islet function in obese diabetic rats (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: